High Intensity Focused Ultrasound Market Size & Growth Forecast 2026–2035, By Segments (Application, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
High Intensity Focused Ultrasound Market size stood at USD 1.37 Billion in 2025 and is predicted to grow at a 7.3% CAGR from 2026 to 2035, reaching USD 2.77 Billion by 2035. The industry revenue for 2026 is calculated at USD 1.46 billion.
Get more details on this report
Request Free Sample ReportHigh Intensity Focused Ultrasound Market Intelligence Snapshot
Regional Market Dynamics
- North America holds 31.83% share due to advanced healthcare infrastructure, established adoption of minimally invasive therapies, and strong integration of image-guided treatment technologies into clinical practice.
- Asia Pacific is growing at an 8.25% CAGR, supported by rising access to non-invasive treatments and increasing investment in modern therapeutic platforms across high-volume hospital environments.
Segment Momentum
- Dermatology held 22.25% share in 2025 due to steady demand for non-invasive skin and aesthetic treatments, short recovery time procedures, and integration into routine outpatient clinical workflows.
- Uterine fibroids is the fastest-growing application as patients and physicians increasingly prefer non-invasive alternatives that preserve the uterus and reduce recovery time compared to conventional surgical procedures.
Market Expansion Drivers
- Rising cancer prevalence increasing adoption of minimally invasive HIFU tumor ablation procedures.
- Expanding cosmetic and neurological applications broadening commercial use of precision ultrasound therapies.
- AI-integrated HIFU platforms improving treatment customization and procedural accuracy across clinical settings.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Key players in the high intensity focused ultrasound market include EDAP TMS S.A. (France), Sonablate Corp. (United States), Chongqing Haifu Medical Technology Co., Ltd. (China), Theraclion SA (France), Verasonics, Inc. (United States), ALPINION MEDICAL SYSTEMS Co., Ltd. (South Korea), Profound Medical Corp. (Canada), Insightec Ltd. (Israel), ULTRAISER SAS (France).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
As cancer case volumes rise, providers are under pressure to expand treatment capacity while limiting hospital stays, procedure-related complications, and recovery burdens, which is increasing demand for the high intensity focused ultrasound market. HIFU tumor ablation fits This transition by offering a non-ionizing, incision-free option for selected solid tumors, making it attractive to hospitals and specialty centers seeking to treat more patients with lower perioperative resource use than conventional surgery. Adoption tends to strengthen first in clinical areas where physicians are prioritizing organ preservation, repeatability, and faster post-procedure recovery, prompting capital investment in image-guided HIFU systems and supporting service-line expansion around oncology care pathways.
Expanding cosmetic and neurological applications broadening commercial use of precision ultrasound therapies
Commercial momentum in the high intensity focused ultrasound market is widening as vendors move beyond oncology into aesthetic procedures and neurological interventions, where precision energy delivery opens new revenue channels for both hospitals and outpatient clinics. In cosmetic use, demand is supported by patient preference for non-surgical skin tightening and body contouring, encouraging providers to adopt HIFU platforms that can generate recurring procedure volumes. In neurology, the ability to target deep brain structures without open surgery is influencing market adoption among advanced care centers that are building focused ultrasound capabilities for movement disorders and other functional indications, giving manufacturers a broader installed-base opportunity and reducing dependence on a narrow set of treatment categories.
AI-integrated HIFU platforms improving treatment customization and procedural accuracy across clinical settings
AI-enabled planning and guidance tools are driving market development in the high intensity focused ultrasound market by making treatment delivery more consistent, personalized, and workflow-efficient. These platforms can help clinicians refine targeting, adapt energy delivery to patient anatomy, and monitor tissue response during procedures, which matters in HIFU because small deviations can affect treatment completeness and safety margins. As a result, AI integration is influencing purchasing decisions among providers that want to reduce operator variability and support wider clinical use beyond highly specialized teams, increasing market penetration of next-generation systems in both established centers and newer adopters.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising cancer prevalence increasing adoption of minimally invasive HIFU tumor ablation procedures | 1.90% | High | North America, Asia Pacific | High | Near Term |
| Expanding cosmetic and neurological applications broadening commercial use of precision ultrasound therapies | 1.60% | Moderate | Asia Pacific, Europe | High | Mid Term |
| AI-integrated HIFU platforms improving treatment customization and procedural accuracy across clinical settings | 1.30% | Moderate | North America, Europe | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held a 31.83% share of the high intensity focused ultrasound market in 2025, supported by established adoption across advanced treatment settings and a healthcare environment that is more able to integrate capital-intensive therapeutic technologies into routine care. The region’s leadership is aided by the presence of specialized providers, stronger procedural infrastructure, and greater familiarity with image-guided, minimally invasive interventions, which helps move high intensity focused ultrasound from selective use cases into broader clinical practice where provider training, patient throughput, and reimbursement readiness matter.
Asia Pacific is projected to expand at an 8.25% CAGR over the forecast period, with the high intensity focused ultrasound market gaining momentum as healthcare systems broaden access to less invasive treatment options and providers continue investing in modern therapeutic platforms. Growth is being propelled by rising utilization in high-volume hospital environments, where demand for non-invasive procedures, expanding clinical acceptance, and ongoing technology adoption create favorable conditions for faster uptake across a wider base of patients and treatment centers.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Clinical IntegrationGermany emphasizes controlled clinical adoption of high intensity focused ultrasound within specialized treatment centers. Manufacturers prioritize regulatory compliance, imaging accuracy, and integration with established hospital treatment protocols.
France 🇫🇷
Targeted Therapy ExpansionFrance is expanding use of high intensity focused ultrasound in targeted treatment protocols across oncology and fibroid management. Providers focus on clinical collaboration, treatment accuracy, and alignment with public healthcare frameworks.
Italy 🇮🇹
Specialized Treatment CentersItaly’s adoption of high intensity focused ultrasound is concentrated in specialized medical centers focusing on non-invasive therapies. Providers emphasize equipment accessibility, procedural efficiency, and integration with existing hospital infrastructure.
Japan 🇯🇵
Advanced Therapeutic InnovationJapan’s high intensity focused ultrasound market is supported by strong adoption in precision oncology and neurology applications. Providers focus on compact system design and alignment with high standards of clinical imaging and treatment precision.
South Korea 🇰🇷
Hospital Technology AdoptionSouth Korea integrates high intensity focused ultrasound into advanced hospital systems focused on minimally invasive therapies. Companies emphasize device efficiency, clinician training, and integration with digital diagnostic imaging platforms.
United States 🇺🇸
Non-Invasive Therapeutics ExpansionIn the U.S., high intensity focused ultrasound is increasingly integrated into minimally invasive treatment pathways across oncology and gynecology. Providers focus on advanced imaging guidance, clinical validation, and hospital system adoption of precision therapeutic platforms.
Segment Leadership and Growth Trends
High Intensity Focused Ultrasound Market Share (%), Application, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportDermatology held a 22.25% share of the high intensity focused ultrasound market in 2025, making it the leading application segment. This position is sustained by steady procedure demand in aesthetic and skin-related treatments, where providers value non-invasive options that can be delivered with limited recovery time and integrated into routine outpatient care. The dermatology segment benefits from repeatable clinical use patterns and broad patient appeal, which helps maintain its share within the high intensity focused ultrasound market.
Uterine fibroids is the fastest-growing application in the high intensity focused ultrasound market as treatment demand shifts toward non-invasive alternatives that can reduce the burden associated with conventional surgical intervention. Growth is being aided by practical clinical adoption in cases where preserving the uterus and shortening recovery time are important considerations for both patients and physicians. Compared with slower-moving applications, uterine fibroids is gaining momentum because the underlying treatment need is clear and the value proposition of focused ultrasound aligns closely with real-world care preferences.
End Use Segment Analysis: Hospitals (Largest & Fastest-Growing Segment)
Hospitals accounted for the largest share of the high intensity focused ultrasound market in 2025 and are also the fastest-growing end-use segment. Their leadership is rooted in the ability to support complex treatment workflows, provide access to specialized imaging and clinical teams, and manage a wider range of patient indications under one care setting. That same operational advantage continues to drive growth in the high intensity focused ultrasound market, as hospitals are typically better positioned than other end users to adopt advanced therapeutic systems, integrate them into established care pathways, and handle the procedural and patient management requirements tied to focused ultrasound treatments.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Application | Uterine Fibroids, Prostate Cancer, Essential Tremor, Dermatology, Breast Cancer, Glaucoma, Backpain, Facetogenic, Others | Dermatology | Uterine Fibroids |
| End Use | Hospitals, Imaging Centers , Others | Hospitals | Hospitals |
Competitive Landscape and Market Positioning
1. EDAP TMS S.A. (France)
2. Sonablate Corp. (United States)
3. Chongqing Haifu Medical Technology Co. Ltd. (China)
4. Theraclion SA (France)
5. Verasonics Inc. (United States)
6. ALPINION MEDICAL SYSTEMS Co. Ltd. (South Korea)
7. Profound Medical Corp. (Canada)
8. Insightec Ltd. (Israel)
9. ULTRAISER SAS (France)
The high intensity focused ultrasound market is witnessing strong innovation activity driven by growing demand for non-invasive therapeutic procedures. Market participants are investing in advanced imaging integration, precision targeting systems, and treatment optimization technologies to improve clinical outcomes. Expanding research initiatives focused on oncology and chronic disease management applications are also contributing to broader adoption and increased technological competitiveness in the sector.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Sonire Therapeutics | May-26 | Sonire Therapeutics secured $18 million in Series A funding to accelerate the clinical development and U.S. market entry of its high-intensity focused ultrasound (HIFU) platform for pancreatic cancer. This financing enables the company to advance its minimally invasive, outpatient treatment technology, marking a strategic step toward commercializing non-invasive therapeutic options for oncology patients with limited surgical alternatives. |
| HistoSonics | Oct-23 | The FDA granted approval for HistoSonics' Edison platform, the first global regulatory authorization for a histotripsy-based system designed to noninvasively destroy liver tissue. This milestone establishes a significant new capability in the focused ultrasound market, representing a novel technological approach to tumor ablation and expanding the clinical landscape for energy-based, image-guided oncology procedures in the United States. |
| Classys | Nov-25 | Classys acquired Brazil-based JL Health, a strategic move to strengthen its distribution network and market presence in South America. This acquisition enhances the company's ability to scale the international commercialization of its energy-based aesthetic medical devices, supporting a broader growth strategy centered on expanding its regulatory foothold and operational reach in key emerging global aesthetic markets. |
| Avenda Health | Oct-24 | Avenda Health entered a strategic partnership with EDAP TMS to integrate robotic ultrasound systems with AI-driven treatment planning tools. This collaboration focuses on optimizing prostate cancer care by combining precision imaging and robotics, aiming to improve patient outcomes through more accurate, personalized ablation procedures and strengthening the competitive integration of digital technologies in minimally invasive oncology. |
| Sonablate | May-26 | Sonablate launched the SONA FUSION global registry to centralize clinical data from international HIFU procedures. This initiative is designed to standardize real-world evidence, improve therapeutic protocols, and facilitate broader clinical adoption. By establishing a robust data-driven framework, the company aims to strengthen the long-term validation and market positioning of its high-intensity focused ultrasound technology within the urology segment. |
| EDAP TMS | Jul-23 | Swiss authorities approved reimbursement for HIFU treatments of prostate cancer, providing a significant catalyst for clinical adoption and commercial scalability in the region. This policy shift supports EDAP TMS's strategy of expanding robotic energy-based therapy applications by reducing financial barriers to patient access, thereby reinforcing the company's long-term leadership position in minimally invasive, ultrasound-guided therapeutic technologies. |
| Hoag | Apr-25 | The Hoag health system deployed new non-invasive ultrasound-based technology for the destruction of liver tumors. This operational expansion into advanced oncology applications highlights the increasing clinical utility of focused ultrasound in precision tumor ablation, reducing dependence on traditional surgical interventions and demonstrating the commercialization of sophisticated, image-guided therapeutic systems within large-scale hospital networks. |
| Profound Medical Inc. | Nov-20 | The FDA approved the Sonalleve MR-guided high-intensity focused ultrasound (MR-HIFU) system for treating osteoid osteoma in the extremities. By integrating high-intensity ablation with real-time temperature monitoring, this regulatory milestone established a new, non-invasive standard for orthopedic oncology applications, demonstrating the successful evolution and clinical validation of MRI-linked ultrasound technology for specialized, site-specific treatment. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
High Intensity Focused Ultrasound Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
High Intensity Focused Ultrasound Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchWhat is the market size of high intensity focused ultrasound?
How is the high intensity focused ultrasound industry projected to perform over the next decade?
How is rising cancer prevalence influencing adoption of High Intensity Focused Ultrasound therapies?
How are expanding clinical applications beyond oncology shaping market adoption of HIFU technologies?
Why does Dermatology lead the high intensity focused ultrasound market?
Why is uterine fibroids emerging as the fastest-growing application?
Why does North America lead the high intensity focused ultrasound market?
How is Asia Pacific expanding in the high intensity focused ultrasound market?
Which organizations are considered leaders in the high intensity focused ultrasound landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization